In Vivo therapeutic potential of mesenchymal stem cell-derived extracellular vesicles with optical imaging reporter in tumor mice model

Mesenchymal stem cells (MSCs) can be used as a therapeutic armor for cancer. Extracellular vesicles (EVs) from MSCs have been evaluated for anticancer effects. In vivo targeting of EVs to the tumor is an essential requirement for successful therapy. Therefore, non-invasive methods of monitoring EVs in animal models are crucial for developing EV-based cancer therapies. The present study to develop bioluminescent EVs using Renilla luciferase (Rluc)-expressing MSCs. The EVs from MSC/Rluc cells (EV-MSC/Rluc) were visualized in a murine lung cancer model. The anticancer effects of EVs on Lewis lung carcinoma (LLC) and other cancer cells were assessed. EV-MSC/Rluc were visualized in vivo in the LLC-efffuc tumor model using optical imaging. The induction of apoptosis was confirmed with Annexin-V and propidium iodide staining. EV-MSC/Rluc and EV-MSCs showed a significant cytotoxic effect against LLC-effluc cells and 4T1; however, no significant effect on CT26, B16F10, TC1 cells. Moreover, EV-MSC/Rluc inhibited LLC tumor growth in vivo. EV-MSC/Rluc-mediated LLC tumor inhibitory mechanism revealed the decreased pERK and increased cleaved caspase 3 and cleaved PARP. We successfully developed luminescent EV-MSC/Rluc that have a therapeutic effect on LLC cells in both in vitro and in vivo. This bioluminescent EV system can be used to optimize EV-based therapy.

[1]  Yongchang Chen,et al.  Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo. , 2006, Experimental and molecular pathology.

[2]  K. Selvakumar,et al.  Quercetin regulates insulin like growth factor signaling and induces intrinsic and extrinsic pathway mediated apoptosis in androgen independent prostate cancer cells (PC-3) , 2010, Molecular and Cellular Biochemistry.

[3]  A. Rydholm,et al.  Mesenchymal stromal cells from primary osteosarcoma are non‐malignant and strikingly similar to their bone marrow counterparts , 2011, International journal of cancer.

[4]  W. Kamps,et al.  Bone marrow-derived cells and tumor growth: contribution of bone marrow-derived cells to tumor micro-environments with special focus on mesenchymal stem cells. , 2009, Critical reviews in oncology/hematology.

[5]  Ralph Weissleder,et al.  Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters , 2015, Nature Communications.

[6]  M. Record,et al.  Exosomes as intercellular signalosomes and pharmacological effectors. , 2011, Biochemical pharmacology.

[7]  S. Lim,et al.  Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs , 2011, Journal of Translational Medicine.

[8]  G. Camussi,et al.  Role of mesenchymal stem cell-derived microvesicles in tissue repair , 2013, Pediatric Nephrology.

[9]  Marleen Keyaerts,et al.  Bioluminescence imaging: looking beyond the light. , 2012, Trends in molecular medicine.

[10]  V. Nikitina,et al.  Spontaneous Aneuploidy and Clone Formation in Adipose Tissue Stem Cells during Different Periods of Culturing , 2009, Bulletin of Experimental Biology and Medicine.

[11]  M. Wood,et al.  Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.

[12]  Zhili Xu,et al.  Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model , 2008, Cell Research.

[13]  M. Andreeff,et al.  Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth? , 2010, Stem cells.

[14]  Katrin J. Svensson,et al.  Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity , 2013, Proceedings of the National Academy of Sciences.

[15]  Y. Jeon,et al.  Exosomes Derived from Mesenchymal Stem Cells Suppress Angiogenesis by Down-Regulating VEGF Expression in Breast Cancer Cells , 2013, PloS one.

[16]  Tian Sheng Chen,et al.  Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs , 2009, Nucleic acids research.

[17]  A. Jemal,et al.  Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[18]  E. Lam,et al.  Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth , 2007, Leukemia.

[19]  Y. Bae,et al.  Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo. , 2008, Stem cells and development.

[20]  Lijun Wu,et al.  Exosomes in cancer: small particle, big player , 2015, Journal of Hematology & Oncology.

[21]  G. Camussi,et al.  Effects of Mesenchymal Stromal Cell-Derived Extracellular Vesicles on Tumor Growth , 2014, Front. Immunol..

[22]  T. Du,et al.  Microvesicles Derived from Human Umbilical Cord Wharton’s Jelly Mesenchymal Stem Cells Attenuate Bladder Tumor Cell Growth In Vitro and In Vivo , 2013, PloS one.

[23]  Robert C. Wolpert,et al.  A Review of the , 1985 .

[24]  Huiling Cao,et al.  Isolation and comparison of mesenchymal stem-like cells from human gastric cancer and adjacent non-cancerous tissues , 2011, Journal of Cancer Research and Clinical Oncology.

[25]  Y. Shirataki,et al.  Tumor-specificity and apoptosis-inducing activity of stilbenes and flavonoids. , 2005, Anticancer research.

[26]  L. Buscail,et al.  Adult Stromal Cells Derived from Human Adipose Tissue Provoke Pancreatic Cancer Cell Death both In Vitro and In Vivo , 2009, PloS one.

[27]  M. Wood,et al.  Exosomes and the emerging field of exosome-based gene therapy. , 2012, Current gene therapy.

[28]  Wen-Lang Lin,et al.  Intercellular nanovesicle‐mediated microRNA transfer: A mechanism of environmental modulation of hepatocellular cancer cell growth , 2011, Hepatology.

[29]  D. Farber,et al.  Transfer of MicroRNAs by Embryonic Stem Cell Microvesicles , 2009, PloS one.

[30]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[31]  Chia‐cheng Chang,et al.  Isolation and identification of mesenchymal stem cells from human lipoma tissue. , 2007, Biochemical and biophysical research communications.

[32]  H. Kijima,et al.  Mesenchymal Stromal Cells Promote Tumor Growth through the Enhancement of Neovascularization , 2011, Molecular medicine.

[33]  P. Krammer,et al.  Tumor Immunology , 2018, Medical Immunology.

[34]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[35]  N. Kosaka,et al.  The therapeutic potential of mesenchymal stem cell‐derived extracellular vesicles , 2013, Proteomics.

[36]  Yuki Takahashi,et al.  Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection. , 2013, Journal of biotechnology.

[37]  Imre Mäger,et al.  Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting , 2015, Journal of extracellular vesicles.

[38]  A. Uccelli,et al.  Mesenchymal stem cells in health and disease , 2008, Nature Reviews Immunology.

[39]  S. Lim,et al.  Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. , 2011, Regenerative medicine.

[40]  Luca Sterpone,et al.  Microvesicles Derived from Adult Human Bone Marrow and Tissue Specific Mesenchymal Stem Cells Shuttle Selected Pattern of miRNAs , 2010, PloS one.

[41]  Yuki Takahashi,et al.  Macrophage-dependent clearance of systemically administered B16BL6-derived exosomes from the blood circulation in mice , 2015, Journal of extracellular vesicles.

[42]  W. Grizzle,et al.  Exosomes and immune surveillance of neoplastic lesions: a review , 2012, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

[43]  Byeong-Cheol Ahn,et al.  In Vivo Cell Tracking with Bioluminescence Imaging , 2015, Nuclear Medicine and Molecular Imaging.

[44]  Laurence Zitvogel,et al.  Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes , 1998, Nature Medicine.

[45]  G. Semenza,et al.  Spontaneous transformation of cultured mouse bone marrow-derived stromal cells. , 2006, Cancer research.

[46]  G. Camussi,et al.  Microvesicles derived from human bone marrow mesenchymal stem cells inhibit tumor growth. , 2013, Stem cells and development.

[47]  A. Kate Sasser,et al.  Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression , 2009, PloS one.

[48]  Caitlin Smith,et al.  A whole picture , 2014, Nature.

[49]  Y. Rui,et al.  Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors , 2013, Stem Cell Research & Therapy.

[50]  Xi-Long Zheng,et al.  Mesenchymal Stem Cell-Derived Microparticles: A Promising Therapeutic Strategy , 2014, International journal of molecular sciences.

[51]  K. Drescher,et al.  Exosomal miRNAs: Biological Properties and Therapeutic Potential , 2012, Front. Gene..

[52]  Sanjiv S. Gambhir,et al.  In Vivo Visualization of Embryonic Stem Cell Survival, Proliferation, and Migration After Cardiac Delivery , 2006, Circulation.

[53]  S. Lim,et al.  Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery. , 2013, Advanced drug delivery reviews.

[54]  Alessandro Busca,et al.  Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. , 2009, Journal of the American Society of Nephrology : JASN.

[55]  Monya Baker,et al.  Whole-animal imaging: The whole picture , 2010, Nature.

[56]  J Ratajczak,et al.  Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication , 2006, Leukemia.

[57]  Maria Ericsson,et al.  Dynamic biodistribution of extracellular vesicles in vivo using a multimodal imaging reporter. , 2014, ACS nano.

[58]  Luigi Biancone,et al.  Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. , 2007, Blood.

[59]  M. Raffeld,et al.  Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma , 2006, The Journal of experimental medicine.

[60]  Sanchita Bhatnagar,et al.  Exosome Function: From Tumor Immunology to Pathogen Biology , 2008, Traffic.

[61]  H. Perlman,et al.  Exosomes From Human CD34+ Stem Cells Mediate Their Proangiogenic Paracrine Activity , 2011, Circulation research.

[62]  Y. DeClerck,et al.  Bone marrow-derived mesenchymal stem cells and the tumor microenvironment , 2010, Cancer and Metastasis Reviews.

[63]  Ha Won Kim,et al.  Exosomes Secreted from CXCR4 Overexpressing Mesenchymal Stem Cells Promote Cardioprotection via Akt Signaling Pathway following Myocardial Infarction , 2015, Stem cells international.

[64]  N. Baldini,et al.  Human bone marrow- and adipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species , 2015, Stem cell research & therapeutics.

[65]  C. Théry,et al.  Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.

[66]  Imre Mäger,et al.  Extracellular vesicles: biology and emerging therapeutic opportunities , 2013, Nature Reviews Drug Discovery.

[67]  G. Camussi,et al.  Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[68]  E. Pae,et al.  Cysteine Dioxygenase Type 1 Inhibits Osteogenesis by Regulating Wnt Signaling in Primary Mouse Bone Marrow Stromal Cells , 2016, Scientific Reports.